Edison Liu
Edison Liu is former president and CEO of The Jackson Laboratory, and the former director of its NCI-designated Cancer Center. His scientific research has focused on the functional genomics of human cancers, particularly breast cancer (identifying the tandem duplicator phenotype genomic configuration), discovering new oncogenes (AXL family of receptor tyrosine kinases), and deciphering the dynamics of gene regulation on a genomic scale that modulates cancer biology. His work has spanned basic sciences to population sciences to translation to the clinic. He has authored over 340 scientific papers and reviews and co-authored two books.
